Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?

被引：0
|
作者：
Diogo Branquinho
Nuno Almeida
Carlos Gregório
José Eduardo Pina Cabral
Adriano Casela
Maria Manuel Donato
Luís Tomé
机构：
[1] Coimbra University Hospital,Gastroenterology Department
[2] Coimbra University,Gastroenterology Centre, Faculty of Medicine
来源：
BMC Gastroenterology | / 17卷
关键词：
Eradication; First-line; Levofloxacin; Sequential therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Levofloxacin-based First-line Helicobacter pylori Eradication Was Not Superior to Standard Therapy in Korea
    Chung, In-sik
    Sung, Hyeyoung
    Lee, In Seok
    Kim, Jin Il
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S36 - S36
  • [22] First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance:: results of three eradication regimens
    Koivisto, TT
    Rautelin, HI
    Voutilainen, ME
    Heikkinen, MT
    Koskenpato, JP
    Färkkilä, MA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) : 773 - 782
  • [23] Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design
    Liou, Jyh-Ming
    Lin, Jaw-Town
    Chang, Chi-Yang
    Chen, Mei-Jyh
    Cheng, Tsu-Yao
    Lee, Yi-Chia
    Chen, Chien-Chuan
    Sheng, Wang-Huei
    Wang, Hsiu-Po
    Wu, Ming-Shiang
    [J]. GUT, 2010, 59 (05) : 572 - 578
  • [24] An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility
    Miyaki, Akira
    Yamaguchi, Kentaro
    Ida, Arika
    Miyauchi, Tatsuomi
    [J]. MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2016, 62 (03) : 234 - 239
  • [25] Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions
    Martos, Maider
    Bujanda, Luis
    Salicio, Yolanda
    Sarasqueta, Cristina
    Ibarra, Begona
    Mendarte, Usua
    Fernandez-Reyes, Maria
    Cosme, Angel
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (12) : 1380 - 1384
  • [26] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Wei Fu
    Zhiqiang Song
    Liya Zhou
    Yan Xue
    Yu Ding
    Baojun Suo
    Xueli Tian
    Li Wang
    [J]. Digestive Diseases and Sciences, 2017, 62 : 1580 - 1589
  • [27] Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
    Fu, Wei
    Song, Zhiqiang
    Zhou, Liya
    Xue, Yan
    Ding, Yu
    Suo, Baojun
    Tian, Xueli
    Wang, Li
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1580 - 1589
  • [28] Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis
    Xiao, Shu-Ping
    Gu, Min
    Zhang, Guo-Xin
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (05) : 528 - 538
  • [29] Tailored therapy based on clarithromycin resistance is effective for the first-line therapy of Helicobacter pylori
    Moon, S.
    Kang, H.
    Lim, C.
    Oh, J.
    [J]. HELICOBACTER, 2020, 25 : 29 - 29
  • [30] Three and seven days levofloxacin/azithromycin-based triple therapies as first-line treatment for Helicobacter pylori eradication
    Finizio, Rosalba
    Nista, Enrico C.
    Candelli, Marcello
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A94 - A94
12345